2015Unpublished venueRequires access

Renal Protective Effects of Traditional Chinese Medcine formula combined with benazepril for Patients with Chronic Kidney Disease Stage 3: A Multi-center,Prospective,Double-blinded,Randomized Controlled Trials of 317 cases

Wang Yong-ju

Open publisher page 0 citations

Abstract

Objective: To investigate the efficacy and safety of combination of Chinese medical formula by differentiation of symptoms and signs and benazepril on patients with chronic kidney disease stage 3. Methods: This is a prospective,double blinded,randomized,controlled trial enrolling a total of 317 patients in per- protocol data set assigned to Traditional Chinese medicine combined with western medicine group( TCMW group,160 cases,general therapy + Chinese medical formula + benazepril 10 mg / d) or western medicine group( WM group,157 cases,general therapy + Chinese medical formula placebo + benazepril 10 mg / d). At baseline and week 24,clinical symptoms,score of Chinese patterns and syndromes,clinical therapeautic effects,24 h proteinuria,ratio of urinary albumin versus creatinine,serum creatinine,urea nitrogen,uric acid,potassium,evaluated glomerular filtration rate( e GFR),stage of chronic kidney disease and safety were assessed. Patients were followed up for 24 weeks. Results: Symptoms and score of Chinese patterns and syndromes were both significantly improved in the two groups at week 24 compared with baseline( P 0. 01),whereas those in the TCMW group were improved better. In the WM group,proteinuria was decreased( P 0. 05) while serum creatinine was increased( P 0. 01),serum creatinine in 31 cases( 19. 7%) were increased 30%,8 cases( 5. 1%)were increased 50%. e GFR in the WM group was decreased,27 cases( 17. 2%) progressed from CKD stage 3 to stage4,only 11 cases( 7. 00%) were improved to CKD stage 2. In the TCMW group,proteinuria( P 0. 05) and serum creatinine( P 0. 01) was significantly decreased,e GFR was increased( P 0. 01),12 cases( 7. 50%) developed to CKD stage 4,27 cases( 16. 90%) were improved to CKD stage 2. Clinical therapeautic effects in the TCMW group were also better than those in the WM group( P 0. 05). No significant difference was found in the adverse effects between the two groups( P 0. 05). Conclusion: Chinese medicine formula by differentiation of symptoms and signs combined with benazepril 10 mg / d can reduced proteinuria and protect renal function more significantly to retard the deterioration renal function compared with the benazeril group.

About this research paper

What this paper is about

Objective: To investigate the efficacy and safety of combination of Chinese medical formula by differentiation of symptoms and signs and benazepril on patients with chronic kidney disease stage 3. Methods: This is a prospective,double blinded,randomized,controlled trial enrolling a total of 317 patients in per- protocol data set assigned to Traditional Chinese medicine combined with western medicine group( TCMW group,160 cases,general therapy + Chinese medical formula + benazepril 10 mg / d) or western medicine group( WM group,157 cases,general therapy + Chinese medical formula placebo + benazepril 10 mg / d). At baseline and week 24,clinical symptoms,score of Chinese patterns and syndromes,clinical therapeautic effects,24 h proteinuria,ratio of urinary albumin versus creatinine,serum creatinine,urea nitrogen,uric acid,potassium,evaluated glomerular filtration rate( e GFR),stage of chronic kidney disease and safety were assessed. Patients were followed up for 24 weeks. Results: Symptoms and score of Chinese patterns and syndromes were both significantly improved in the two groups at week 24 compared with baseline( P 0. 01),whereas those in the TCMW group were improved better. In the WM group,proteinuria was decreased( P 0. 05) while serum creatinine was increased( P 0. 01),serum creatinine in 31 cases( 19. 7%) were increased 30%,8 cases( 5. 1%)were increased 50%. e GFR in the WM group was decreased,27 cases( 17. 2%) progressed from CKD stage 3 to stage4,only 11 cases( 7. 00%) were improved to CKD stage 2. In the TCMW group,proteinuria( P 0. 05) and serum creatinine( P 0. 01) was significantly decreased,e GFR was increased( P 0. 01),12 cases( 7. 50%) developed to CKD stage 4,27 cases( 16. 90%) were improved to CKD stage 2. Clinical therapeautic effects in the TCMW group were also better than those in the WM group( P 0. 05). No significant difference was found in the adverse effects between the two groups( P 0. 05). Conclusion: Chinese medicine formula by differentiation of symptoms and signs combined with benazepril 10 mg / d can reduced proteinuria and protect renal function more significantly to retard the deterioration renal function compared with the benazeril group.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To investigate the efficacy and safety of combination of Chinese medical formula by differentiation of symptoms and signs and benazepril on patients with chronic kidney disease stage 3. Methods: This is a prospective,double blinded,randomized,controlled trial enrolling a total of 317 patients in per- protocol data set assigned to Traditional Chinese medicine combined with western medicine group( TCMW group,160 cases,general therapy + Chinese medical formula + benazepril 10 mg / d) or western medicine group( WM group,157 cases,general therapy + Chinese medical formula placebo + benazepril 10 mg / d). At baseline and week 24,clinical symptoms,score of Chinese patterns and syndromes,clinical therapeautic effects,24 h proteinuria,ratio of urinary albumin versus creatinine,serum creatinine,urea nitrogen,uric acid,potassium,evaluated glomerular filtration rate( e GFR),stage of chronic kidney disease and safety were assessed. Patients were followed up for 24 weeks. Results: Symptoms and score of Chinese patterns and syndromes were both significantly improved in the two groups at week 24 compared with baseline( P 0. 01),whereas those in the TCMW group were improved better. In the WM group,proteinuria was decreased( P 0. 05) while serum creatinine was increased( P 0. 01),serum creatinine in 31 cases( 19. 7%) were increased 30%,8 cases( 5. 1%)were increased 50%. e GFR in the WM group was decreased,27 cases( 17. 2%) progressed from CKD stage 3 to stage4,only 11 cases( 7. 00%) were improved to CKD stage 2. In the TCMW group,proteinuria( P 0. 05) and serum creatinine( P 0. 01) was significantly decreased,e GFR was increased( P 0. 01),12 cases( 7. 50%) developed to CKD stage 4,27 cases( 16. 90%) were improved to CKD stage 2. Clinical therapeautic effects in the TCMW group were also better than those in the WM group( P 0. 05). No significant difference was found in the adverse effects between the two groups( P 0. 05). Conclusion: Chinese medicine formula by differentiation of symptoms and signs combined with benazepril 10 mg / d can reduced proteinuria and protect renal function more significantly to retard the deterioration renal function compared with the benazeril group.

Key concepts: Benazepril, Medicine, Creatinine, Proteinuria, Renal function, Kidney disease, Internal medicine, Gastroenterology

Related papers

Back to paper searchBrowse research topicsOriginal source
Renal Protective Effects of Traditional Chinese Medcine formula combined with benazepril for Patients with Chronic Kidney Disease Stage 3: A Multi-center,Prospective,Double-blinded,Randomized Controlled Trials of 317 cases — Research Paper | ScholarLens